Advertisement

Topics

Houlihan Lokey Company Profile

09:14 EST 12th December 2017 | BioPortfolio

Houlihan Lokey is an international investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm is ranked globally as the No. 1 restructuring advisor, the No. 1 M&A fairness opinion advisor over the past 10 years, and the No. 1 M&A advisor for U.S. transactions under $1 billion, according to Thomson Reuters. Houlihan Lokey has been advising clients for more than 40 years and now has 14 offices and 850 employees in Europe, the United States and Asia. The firm serves over 1,000 clients each year, ranging from closely held companies to Global 500 corporations. For more information, visit www.HL.com.


News Articles [5 Associated News Articles listed on BioPortfolio]

Synspira’s Novel Glycopolymer Improves Effectiveness of Antibiotics Against Drug-resistant ...

MacDougall Biomedical CommunicationsAmanda Houlihan, 781-235-3060ahoulihan@macbiocom.com Read more...

IntriCon Names Jim Houlihan Vice President of Direct-to-Consumer Hearing Healthcare Sales, President of Hearing Help Express

IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced that it has named Jim H...

Sheridan Capital Partners Completes Majority Recapitalization of Smile Doctors in Partnership with Linden Capital Partners and Management

Sheridan Capital Partners (“Sheridan” or “SCP”) announced today it has completed a majority recapitalization of existing portfolio company Smile Doctors (“the Company”...

Sentinel Capital Partners Sells WellSpring Consumer Healthcare

NEW YORK, Sept. 26, 2017 /PRNewswire/ -- Sentinel Capital Partners, a private equity firm that invests in promising companies in the lower middle market, today announced the sale of WellSpring Co...

Linden and Northlane Complete Merger of Chesapeake IRB and Schulman IRB to Create Advarra, the Premier Independent Institutional Review Board for Research

Linden Capital Partners (“Linden”) and Northlane Capital Partners (“Northlane”), announced today the merger of their portfolio companies

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Houlihan Lokey

Houlihan Lokey is an international investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm is r...

Houlihan Lokey, Inc.

ORIX USA Asset Management

ORIX USA is a diversified financial company with more than $5 billion of assets in sectors spanning commercial finance, venture finance, commercial real estate, mortgage backed se...

Houlihan Smith & Company, Inc.

Circle Pharma, Inc.

Circle Pharma is an early stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell permeable macrocycle peptide th...

More Information about "Houlihan Lokey" on BioPortfolio

We have published hundreds of Houlihan Lokey news stories on BioPortfolio along with dozens of Houlihan Lokey Clinical Trials and PubMed Articles about Houlihan Lokey for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Houlihan Lokey Companies in our database. You can also find out about relevant Houlihan Lokey Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record